摘要
目的:调查某院肝炎或肝硬化患者质子泵抑制药的使用情况,并进行合理性评价。方法:对某院2013~2014年诊断为“肝炎”或“肝硬化”的住院患者质子泵抑制药的应用情况进行回顾性分析,并对使用合理性进行评价。结果:共收集到211份病历,使用质子泵抑制药192例,使用率91%;不合理用药62例,占总病例数的29.3%;用药不合理主要表现为用药疗程过长(24.5%),预防用药指征不充分(5.7%),无目的用药(2.6%)。结论:肝炎或肝硬化患者质子泵抑制药的不合理使用十分普遍,临床药师应加强药学监护,促进合理用药。
Objective:To investigate the use of proton pump inhibitors ( PPIs) in the patients with cirrhosis or hepatitis in one hospital and evaluate the use rationality .Methods:A retrospective study was carried out on 211 patients with the diagnosis of hepatitis or cirrhosis in the infectious disease ward between 2013 and 2014 , and the use rationality of PPIs was evaluated .Results: A total of 211 cases were inspected, and among them, 192 ones were treated with PPIs (91%) with 62 ones treated with PPIs irrationally, which accounted for 29.3%of the total cases.The main irrational use of PPIs was long treatment course (24.5%), inadequate prophylaxis indications (5.7%) and purposeless use (2.6%).Conclusion: Irrational use of PPI is common in hepatitis or cirrhosis patients . Clinical pharmacists should strengthen pharmaceutical care to improve the rational drug use .
出处
《中国药师》
CAS
2016年第7期1342-1344,共3页
China Pharmacist
关键词
质子泵抑制药
肝炎
肝硬化
合理用药
Proton pump inhibitor
Hepatitis
Cirrhosis
Rational drug use